Browsed by
Category: Press Releases

Emalex Biosciences Acquires Psyadon Pharmaceuticals to Develop Novel Treatment for Pediatric Tourette Syndrome

Emalex Biosciences Acquires Psyadon Pharmaceuticals to Develop Novel Treatment for Pediatric Tourette Syndrome

CHICAGOAug. 14, 2018 /PRNewswire/ — Biopharmaceutical company Emalex Biosciences (Emalex), the newest member of the Paragon Biosciences (Paragon) portfolio of companies, today announced it acquired Psyadon Pharmaceuticals and the exclusive rights to develop, register and market ecopipam, a new chemical entity with orphan drug designation for the treatment of pediatric Tourette Syndrome (TS) in patients under 16 years of age. ...  Read more

BIO Investor Forum

BIO Investor Forum

Program

The BIO Investor Forum delivers a rich program that features corporate presentations and panel debates on the sweet spots and growth challenges facing the industry.  The BIO Investor Forum features: ...  Read more

Announcing the Inova Translational Research Funding Program (ITRF)

Announcing the Inova Translational Research Funding Program (ITRF)

Inova Health System, through the Office of Research and Commercialization, is excited to share with you the launch of a new research funding initiative, the Inova Translational Research Funding Program (ITRF). This program, which will fund cutting-edge translational research across our system, was created to encourage the development of research talent at Inova and to foster interdepartmental, interinstitutional, academic and industry collaborations. We hope that these partnerships will lead to larger research endeavors that advance our mission to help our patients and our community. ...  Read more

National Bioscience Industry Report Shows $2T Economic Impact, Accelerated Venture Capital Investment & Job Growth

National Bioscience Industry Report Shows $2T Economic Impact, Accelerated Venture Capital Investment & Job Growth

Boston, MA (June 5, 2018) –  A study released today at the BIO International Convention shows that the U.S. bioscience industry has reached $2 trillion in annual economic impact while maintaining accelerated venture capital investment and job growth numbers. Among U.S. technology sectors, the bioscience industry has held a leading position as an economic driver and job generator. ...  Read more

Sirnaomics Closed Series C1 Financing of US$25 Million and Expands Clinical Programs of Anti-Fibrosis and Anti-Cancer RNAi Therapeutics

Sirnaomics Closed Series C1 Financing of US$25 Million and Expands Clinical Programs of Anti-Fibrosis and Anti-Cancer RNAi Therapeutics

GAITHERSBURG, MD, June 6, 2018— Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in development of RNAi therapeutics, announces today that it has closed Series C1 financing of US$25 Million (RMB160 Million). This round of financing was led by Yuexiu New Industrial Investment, followed by Sangel Biomedical Venture Capital, HuaKong Equity Investment and Qianhai Shenghui Investment. The proceeds will be used to expand the clinical programs of the lead anti-fibrosis and anti-cancer RNAi therapeutics, strengthen the management team to support growth ...  Read more

John Shetrone, Jr. of Vision Named CEO of the Year by Maryland Tech Council

John Shetrone, Jr. of Vision Named CEO of the Year by Maryland Tech Council

GLEN BURNIE, MD, May 18, 2018 – Vision Technologies, Inc. (Vision), a leading systems integrator, is proud to announce that President and CEO John Shetrone, Jr. was named Chief Executive Officer of the Year by the Maryland Tech Council (MTC) at its 30th Industry Awards Celebration. Vision was also a finalist in the Technology Company of the Year award category. ...  Read more

Novavax Promotes John J. Trizzino to Expanded Role as Chief Business Officer and Chief Financial Officer

Novavax Promotes John J. Trizzino to Expanded Role as Chief Business Officer and Chief Financial Officer

Gaithersburg, MD, March 14, 2018 – Novavax, Inc., (Nasdaq: NVAX) today announced the promotion of John J. Trizzino to Senior Vice President, Chief Business Officer (CBO) and Chief Financial Officer (CFO). Mr. Trizzino has been serving as Senior Vice President, Commercial Operations, since 2014. As CBO at Novavax, he is now responsible for all pre-commercial and commercial launch strategy and execution as well as public relations. As CFO, he is now responsible for financial reporting, corporate funding, and investor relations. ...  Read more

Akonni Biosystems Announces Strategic Partnership with Major Chinese Diagnostics Company Righton

Akonni Biosystems Announces Strategic Partnership with Major Chinese Diagnostics Company Righton

Akonni Biosystems Inc. and Chinese in vitro diagnostics company, Righton, announce a commercial agreement that enables Righton to sell Akonni’s products for nucleic acid purification and molecular diagnostics to researchers, clinical laboratories, and hospitals in China. The products to be sold include TruTip®, Akonni’s best-in-class sample preparation technology, which is low-cost and simple, yet highly effective at purifying DNA and RNA from the most difficult sample types. ...  Read more